Sale!

GJB2 Gene Knuckle Pads and Leukonychia Sensorineural Deafness Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GJB2 gene, associated with the condition involving knuckle pads, leukonychia (white nails), and sensorineural deafness, is the focus of a specialized genetic test available at DNA Labs UAE. This comprehensive analysis is designed to identify mutations in the GJB2 gene, which can indicate a predisposition to these specific physical manifestations along with hearing impairment. Sensorineural deafness is a type of hearing loss resulting from damage to the inner ear or to the nerve pathways from the inner ear to the brain, often having genetic roots. The presence of knuckle pads (thickened skin over the knuckles) and leukonychia further points towards a unique genetic syndrome linked to the GJB2 gene.

Understanding the genetic underpinning of these conditions can be crucial for early intervention, management strategies, and providing a clear diagnosis for affected individuals. The test, priced at 4400 AED, is a significant step towards personalized medicine, allowing for tailored approaches to treatment and care based on one’s genetic makeup. Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, clients are assured of accurate, reliable results and comprehensive support through their diagnostic journey.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GJB2 Gene Knuckle Pads and Leukonychia Sensorineural Deafness Genetic Test

At DNA Labs UAE, we offer the GJB2 Gene Knuckle Pads and Leukonychia Sensorineural Deafness Genetic Test at a cost of AED 4400.0. This test is designed to diagnose and identify mutations in the GJB2 gene that may be associated with sensorineural deafness, knuckle pads, or leukonychia.

Test Details

The GJB2 gene is responsible for encoding a protein called connexin 26, which plays a crucial role in the formation and functioning of gap junctions in the inner ear and skin. Gap junctions are specialized channels that allow the exchange of ions and small molecules between adjacent cells.

Mutations in the GJB2 gene can lead to various disorders, including sensorineural deafness, knuckle pads, and leukonychia. Sensorineural deafness refers to a type of hearing loss that occurs due to damage or malformation of the inner ear or auditory nerve pathways. Knuckle pads are thickened areas of skin that develop on the knuckles, and leukonychia refers to the presence of white spots or streaks on the nails.

Our GJB2 Gene Knuckle Pads and Leukonychia Sensorineural Deafness Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes. By performing this test, healthcare professionals can determine if there are any mutations in the GJB2 gene that could explain the presence of these symptoms.

Test Components and Price

  • Test Name: GJB2 Gene Knuckle Pads and Leukonychia Sensorineural Deafness Genetic Test
  • Price: AED 4400.0

Sample Condition and Report Delivery

We require either blood or extracted DNA, or one drop of blood on an FTA card as the sample condition for this test. The report will be delivered within 3 to 4 weeks.

Test Type and Doctor

  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor

Test Department and Pre-Test Information

  • Test Department: Genetics
  • Pre-Test Information: Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS15

By undergoing the GJB2 Gene Knuckle Pads and Leukonychia Sensorineural Deafness Genetic Test, individuals can gain valuable information for diagnosis, prognosis, and potentially guiding treatment decisions. Contact DNA Labs UAE today to schedule your test.

Test Name GJB2 Gene Knuckle pads and leukonychia sensorineural deafness Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS15
Test Details

The GJB2 gene is responsible for encoding a protein called connexin 26, which plays a crucial role in the formation and functioning of gap junctions in the inner ear and skin. Gap junctions are specialized channels that allow the exchange of ions and small molecules between adjacent cells.

Mutations in the GJB2 gene can lead to various disorders, including sensorineural deafness, knuckle pads, and leukonychia. Sensorineural deafness refers to a type of hearing loss that occurs due to damage or malformation of the inner ear or auditory nerve pathways. Knuckle pads are thickened areas of skin that develop on the knuckles, and leukonychia refers to the presence of white spots or streaks on the nails.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the case of the GJB2 gene, NGS genetic testing can be used to identify mutations or variations in the gene that may be associated with sensorineural deafness, knuckle pads, or leukonychia.

By performing NGS genetic testing on an individual, healthcare professionals can determine if there are any mutations in the GJB2 gene that could explain the presence of these symptoms. This information can be valuable for diagnosis, prognosis, and potentially guiding treatment decisions.